Free Trial
NASDAQ:AAPG

Ascentage Pharma Group International (AAPG) Stock Price, News & Analysis

Ascentage Pharma Group International logo
$18.46 -0.51 (-2.69%)
As of 03/25/2025 04:00 PM Eastern

About Ascentage Pharma Group International Stock (NASDAQ:AAPG)

Key Stats

Today's Range
$18.31
$18.96
50-Day Range
N/A
52-Week Range
$16.50
$21.40
Volume
15,886 shs
Average Volume
89,214 shs
Market Capitalization
$1.61 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.

Remove Ads
Receive AAPG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ascentage Pharma Group International and its competitors with MarketBeat's FREE daily newsletter.

AAPG Stock News Headlines

Ascentage Pharma Group Int Ltd (AAPG)
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars
Musk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to help build human colonies on the Red Planet. And here on Earth? Optimus is about to change everything.
AAPG Ascentage Pharma Group International
See More Headlines

AAPG Stock Analysis - Frequently Asked Questions

Ascentage Pharma Group International's stock was trading at $18.67 on January 1st, 2025. Since then, AAPG stock has decreased by 1.1% and is now trading at $18.46.
View the best growth stocks for 2025 here
.

Ascentage Pharma Group International (AAPG) raised $126 million in an IPO on Friday, January 24th 2025. The company issued 7,325,000 shares at a price of $17.25 per share.

Ascentage Pharma Group International's quiet period expired on Wednesday, March 5th. Ascentage Pharma Group International had issued 7,325,000 shares in its public offering on January 24th. The total size of the offering was $126,356,250 based on an initial share price of $17.25. During the company's quiet period, insiders and any underwriters involved in the IPO were prevented from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

Shares of AAPG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
3/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:AAPG
Previous Symbol
NASDAQ:AAPG
Web
N/A
Fax
N/A
Employees
600
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$903.03 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$1.61 billion
Optionable
N/A
Beta
N/A
The 10 Best Stocks to Own: Spring 2025 Cover

Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.

Get This Free Report

This page (NASDAQ:AAPG) was last updated on 3/26/2025 by MarketBeat.com Staff
From Our Partners